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Abstract 
Background: Knee medial collateral ligament (MCL) sprain is common in athletes, which keeps them away 
from trainings. Platelet-rich plasma (PRP) injection is used as an adjunct for treatment of musculoskeletal 
injuries. This study was supposed to define effect of PRP injection on high-grade MCL sprain healing, in 
comparison to rehabilitation alone. 
Materials and Methods: This study was performed on 46 healthy athletes with high-grade MCL sprains who 
came to sports medicine clinic of Taleghani Hospital, Tehran over a one-year period (2017-2018). In first visit 
injury grade, its location, baseline pain, Lysholm score and joint stability was determined. Participants 
randomly allocated to 2 groups (n=23), “group A” had 12-week functional rehabilitation and “group B” had the 
same rehabilitation plus a single PRP injection. At 4-week intervals valgus stress testing, pain and Lysholm 
scores was reassessed. The scores of 4th, 8th and 12th weeks was compared to the baseline scores. 
Results: Mean baseline pain score in control and intervention group was 5.09±0.949 and 5.26±0.810 
respectively that in the fourth week of study reduced to 1.30±0.765 and 2.43±0.507 (p<0.001). In 
intervention group, fourth week pain was significantly reduced while stability and Lysholm scores of the 
groups had no significant difference. 
Conclusion: PRP injection had a short-term statistically significant pain reduction effect that may assist in 
faster rehabilitation progress, shorter return to play and less detraining which is crucial to professional athletes.  
Keywords: Knee medial collateral ligament, Platelet rich plasma, Sprain, Joint instability, Analog pain scale, 
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Introduction 
Platelet-rich plasma (PRP) was originally used in 
clinical practice as an adjunct to surgery to assist in 
the healing of various tissues. It is used in open-heart 
surgery, prosthetic surgery to promote tissue healing, 
implant integration, and to control blood loss. 
Application of activated PRP has an effect on pain and 
analgesic use following open subacromial 
decompression surgery. Injectable PRP is used for the 
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management of common muscle, tendon and 
cartilage injuries. Platelets’ α granules contain more 
than 30 bioactive proteins, many of which play a role 
in hemostasis or tissue healing. They contain, 
synthesize and release large amounts of biologically 
active proteins that promote tissue regeneration1.  
PRP injection in knee osteoarthritis (OA) has been 
shown to have anti-inflammatory effects through 
growth factors such as TGF- and IGF1, stimulatory 
effects on mesenchymal stem cells and fibroblasts. 
Multiple studies have indicated that PRP is superior 
to hyaluronic acid (HA) and corticosteroids in 
improving patient-reported pain and function2. In a 
case of lateral ankle sprain with complete tear of 
ATFL, PRP injection caused complete healing and 
early ankle stabilization therefore it can prevent 
chronic ankle instability3. Three cases who sustained 
high-grade ulnar collateral ligament (UCL) injury 
underwent two PRPs and cleared to full return to 
play at a mean 36-day post injury. Follow-up 
examination demonstrated full range of motion, 
without tenderness over the UCL, stability also 
improved, although not symmetric to the 
contralateral side. All continued to play at the same 
level as preinjury without any complaints, none had 
recurrence injury4. PRP aims to mediate 
inflammatory and catabolic factors through the 
secretion of anti-inflammatory factors and 
chemotaxis effects. A growing number of studies 
have demonstrated the clinical benefit of PRP for OA 
management5. Evidence for PRP injection in knee 
OA showed inhibition long-term pain and improving 
its function6. Intra-articular knee PRP injection may 
be an effective alternative treatment for mild OA. 
PRP may reduce pain of lateral epicondylitis and 
rotator cuff injuries7. A single PRP injection was 
better in knee OA compared to HA or NSAID 
therapy, but had no effect on cartilage progression8. 
In a retrospective study assessing PRP injections for 
chronic tendinopathy, a moderate improvement in 
pain was observed in most cases particularly in 
patellar and lateral epicondylar tendinopathy, female 
patients, upper extremity tendinopathy and older 
patients9. Evidence suggest that PRP may provide 
some benefit in patients with knee OA or lateral 
epicondylitis but appears to be inconsistent or shows 
a minimal benefit in rotator cuff repair, patellar and 
Achilles tendinopathies, hamstring injuries, ACL 
repair and medial epicondylitis10. PRP injections in 25 
patients with partial elbow medial ulnar collateral 
ligament (MUCL) tears plus rehab, 22 patients (96%) 
could return to play and demonstrated reconstitution of 
the MUCL on MRI, this treatment was less effective in 
patients with previous surgery for MUCL11.  
Medial collateral ligament (MCL) sprains are among 
the most common knee injuries in young athletes, 
more common in men, in any sport, especially those 
involving contact or pivoting (e.g. soccer, rugby, 
basketball, skiing)12. MCL originates on the medial 
femoral condyle and inserts 5 cm distal to the joint line 
on the tibia, is about 11 cm long, 1.5 cm wide. Medial 
knee has three layers, composed of a superficial and 
deep band that is the primary medial knee stabilizer. 
Superficial MCL converges with the posterior oblique 
ligament, forming the posteromedial joint capsule that 
plays an important stability role. Deep MCL forms a 
thickening in the middle portion of medial joint 
capsule and attaches to the medial meniscus. MCL is 
static medial stabilizer, resisting valgus and external 
rotation stresses. Superficial MCL is the primary 
restraint to valgus stress in slight flexion. Most injuries 
occur with a direct blow to the lateral of slightly bent 
knee. The most common injury mechanism is forced 
valgus to a planted foot (isolated MCL), also external 
rotation in an open kinetic chain along with valgus 
force (MCL sprain may be associated with posterior 
oblique ligament and posteromedial components’ 
injury). It has three grades (I – III). Grade I injury is 
partial tearing without laxity. Grade II consist of 
partial tearing with joint opening up to 5 mm. Grade 
III leads to joint instability (>10° of joint opening)13. 
MCL is exrtrasynovial therefore responds well to 
conservative treatment and almost none needs surgery. 
Mean rehabilitation time to return to sport depends on 
the severity of injury, about 8 weeks in 2nd degree 
injuries and 12 weeks in 3rd degree injuries14. The aim 
of our study was to answer this question, Can PRP 
injection help to injured ligament to heal sooner? 
Methods 
This study was a randomized clinical trial and done 
over one-year period (2017-2018). Participants were 
healthy young athletes, 15-35 years old, who had come 
for a visit to orthopedic clinic for their medial knee 
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Figure 1. Flowchart of the study. 
 
pain and referred to sports medicine clinic.  Inclusion 
criteria were 1) 15-35 years old, 2) Having injured 
their MCL during a sport activity, 3) Grade 2 or 3 
MCL sprain, 4) Not having surgery indications (e.g. 
Associated ACL, PCL, POL, PMC, meniscal injury, 
avulsion of the MCL and tibia side complete MCL 
rupture). Exclusion criteria were 1) Having an 
indication for MCL repair/reconstruction, 2) Having 
absolute/ relative Contraindications for PRP (e.g. 
Platelet disorders, Severe thrombocytopenia, local 
infection around the knee, Hemodynamic instability / 
hematological or bone malignancies, recent use of 
corticosteroid, NSAID’s, cigarette smoking, addiction, 
3) uncontrolled diabetes mellitus, 4) pregnancy, 
Nursing mother, 5) not willing to have the injection 6) 
Not willing to comply with the rehabilitation program 
or participate in the follow up sessions. Accordingly, 
in the first visit, each patient had to fill in 
questionnaires (personal information, age, weight, 
height, sport, discipline, chief complaint, date and 
mechanism of injury, past medical history, drug/ habit/ 
allergy history) then was examined and our orthopedic 
Table 1: Age distribution of the participants. 
Participants’ Age 
 Mean SD Min Max P value 
Control 26.09 4.78 18 34 0.039 
PRP 27.48 4.99 17 35 
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surgeon graded his injury, radiographs being 
requested. If inclusion criteria were met, patient was 
referred to sport medicine clinic. The process of 
treatment was explained and discussed in details, due 
to ethical considerations each patient had to read and 
sign the informed consent forms. In the sport 
medicine clinic, each patient was reevaluated for 
precise location of injury. VAS pain score assessed 
their pain; their knee stability was assessed by valgus 
stress testing examination and Lysholm knee score 
was calculated and recorded for later comparison. 
Regardless of gender, age or sport the patients were 
divided randomly by “random block assignment” 
into 2 groups, 23 people in each group. Group A or 
control group was supposed to be rehabilitated by 
physical therapists according to a phased functional 
rehabilitation program including modalities for pain 
and inflammation reduction, restoring range of 
motion (ROM) of the joint, manual soft tissue 
therapeutic modalities, gradual progressive 
strengthening of muscles, neuromuscular 
proprioceptive balance training and in the last phase 
sport specific agility trainings, depending on the grade 
of injury, patients’ symptoms and signs. Group B or 
intervention group received a single PRP injection at 
the site of injury and 7 days post injection started the 
same functional rehabilitation program. Each patient 
attends first two sessions of rehabilitation phase in the 
clinic, needed modalities explained and exercises 
taught in order to performed them correct and 
effectively. At 4 weeks, intervals each patient was 
reassessed for pain, Lysholm score and joint stability. 
The scores of each period were recorded to allow 
comparison to the initial scores. The pain of 
participants was quantified by visual analogue scale 
(VAS) (the least pain was 0 and the most pain was 10), 
by looking at the VAS scale ruler15. Lysholm knee 
score as a functional score was used to quantify 
athletes’ abilities that is valid as patient-administered 
scores. It has acceptable test-retest reliability 
(intraclass correlation coefficient = 0.9)16. It is a 
functional score that is calculated by summing the 
points of a questionnaire, which covers 8 individual 
activity related items pain, giving way sensation, 
locking sensation, squatting, climbing stairs, swelling 
after activity, using cane or crutches and limping. 
Total Lysholm score in a normal person is 100 and in 
Table 2: Sex distribution of the participants. 
 Control PRP  
No.(%) Male 13(56.5) 15(65.2) P value 





Figure 2. Mean VAS score of the groups of the study. 
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exhausted person, the score is lowered (Lysholm 
questionnaire showed in the appendix page). Knee 
stability was assessed by Valgus stress testing in two 
positions: 0 and 30 degrees’ flexion, which identify 
the integrity of MCL, Posteromedial corner (PMC) 
elements and can differentiate isolated MCL sprains 
from associated MCL and posteromedial components’ 
injuries17. Grading is based on the joint gap on Valgus 
stress testing in flexion and presence or absence of 
endpoint. Other tests like anterior drawer testing, 
Lachman’s, joint line tenderness are also used for 
other knee structure examination. Intervention group 
had a platelet count prior to venipuncture, also the 
final PRP was checked for platelet count. Most of the 
previous clinical trials used one injection11, 18-21 and 
some two injections and in a case report, they used 3 
PRP injections22,23, in this study we used one injection. 
Special PRP kits was used “Standard Kit” that is 
specifically produced for PRP production by a local 
Table 4: Participants sport type; No (%). 
Sports Control Intervention P 
value 











Figure 3. Mean Lysholm scores of the groups of the study. 
 
Table 3: Sport distribution of participants. 












Roller skater 1(2.2%) 
Kick boxer. 1(2.2%) 
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company, which is a colleague of “Iranian Blood 
Donation Organization”, which needs 25-30 ml of 
peripheral blood and uses 2 phases of centrifugation 
before PRP extraction and provides 4 ml of PRP. 
PRP injected was done under US guidance. We did 
not have any sample loss. Data analysis done by 
SPSS 16.0 and significant level of statistical tests 
were considered 0.05. As other interventions (dry 
needling, saline injection) had therapeutic effects, we 
couldn’t do patient blinding, our statistical analyst 
was unaware of intervention type. Figure1 shows 
stages of the study.  
The study subject was approved by the Ethics 
Committee of the School of Medicine of SBMU with 
the Code of Ethics IR.SBMU.MSP.REC.1396.74. 
Results 
Forty-six athletes with isolated grade 2 and 3 knee 
MCL sprains participated in the study. There was no 
statistically significant difference regarding age, sex, 
weight, height, body mass index (BMI) and injury 
grades between the participants of the groups of study. 
Grade 3 injury was 77% lower in females; injury 
severity was significantly lower in females than males 
(p≤0.047). Compared to first visit joint stability was 
improved statistically significant in the 8 weeks of 
study in both groups (P<0.001), regarding joint 
stability there was no statistically significant 
difference between the groups. 
Comparing first visit VAS scores of the groups 
showed no statistically significant difference between 
the two groups (p=0.507), by the 4 weeks of the study 
VAS score in the intervention group was statistically 
significant lower than control group (p<0.001). There 
was no statistically significant difference in VAS score 
between the groups in the 8 and 12 weeks of the study 
(p=0.458 and 0.639). Bonferroni correction showed 
that VAS score of the groups lowered statistically 
significant (p<0.001) from first visit to 4, 8 and 12 
weeks. Analysis of variances of repetitive measures 
revealed that cross effect of time and group was 
statistically significant (p<0.001) therefore the changes 
of VAS score during the study was significantly 
Table 5: Description & comparison of participants’ Weight, Height, BMI. 
 Control PRP P value 
Max-Min MeanSD Max-Min MeanSD 
Weight 102.5-46.8 72.8813.36 114-56.5 80.1613.69 0.075 
Height 185-145 169.39.31 204-158 17310.71 0.218 
BMI 33.86-20.31 25.273.26 30.92-22.48 26.642.57 0.120 
 
 
Table 6: Participants injury severity. 
 All cases No (%) Control no. Intervention no. 
Grade 2 30(65.2%) 16 14 
Grade 3 16(34.8%). 7 9 
 
 Table 7: Sex distribution & injury severity. 
 Male Female 
Grade 2 15 (53.6%) 15 (83.3%) 
Grade 3 13(46.4%) 3(16.7%) 
 
 
Table 8: Injury grades by sport type. 
 Contact Sports Semi-contact Non-contact 
Grade 2 10 14 6 
Grade 3 9 7 0 
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different in the groups (p<0.001) and pain was 
statistically significant reduced in both groups. 
Group effect was meaningful (p<0.008).   
Table 9: Description & comparison of Injury severity by Age, weight, height & BMI. 
 Grade 2 Grade 3  
Mean SD Mean SD Chance ratio (95%CI) P value 
Age 26.43 4.69 27.44 5.32 1.05 (0.919-1.19) 0.503 
Weight 73.51 14.35 82.16 11.30 1.05 (0.999-1.11) 0.055 
Height 169.6 10.83 174.1 8.09 1.05 (0.981-1.12) 0.164 
BMI 25.39 3.26 27.02 2.05 1.22 (0.973-1.52) 0.086 
 
 Table 10: Joint stability changes in control group by 8
th week. 
 8th week Total 
Stable +1 laxity 
1stvisit +1 laxity No. 16 0 16 
% 69.6% 0.0% 69.6% 
+2 laxity No. 4 3 7 
% 17.4% 13.0% 30.4% 
Total No. 20 20 23 
% 87.0% 13.0% 100.0% 
 
 Table 11: Joint stability changes in intervention group by 8
th week. 
 8th week Total 
Stable +1 laxity 
1stvisit +1 laxity No. 15 0 15 
% 65.2% 0.0% 65.2% 
+2 laxity No. 6 2 8 
% 26.1% 8.7% 34.8% 
Total No. 21 2 23 
% 91.3% 8.7% 100.0% 
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Lysholm scores of the groups in the first visit, 4, 8 
and 12 weeks’ visits had no statistically significant 
difference (p=0.363). Regardless of the group, 
Lysholm score had a statistically significant steady 
rise from first to 12 weeks (p<0.001). Mean Lysholm 
scores of the groups in the first visit (p=0.375) also in 
4 (p=0.375), 8 (p=0.571) and 12 weeks (p=0.613) 
had no statistically significant difference. Bonferroni 
correction also showed that mean Lysholm scores in 
4, 8 and 12 weeks compared to the first visit had 
statistically significant improved (p<0.001). Mean 
Lysholm scores of the groups had no meaningful 
differences, group effect not detected (p=0770). 
Discussion 
Healing process starts with platelet aggregation and 
clot formation and forms a scaffold, which acts as a 
Table 12: Describes pain VAS score of groups. 
 Control PRP  
Time Mean SD Mean SD P value* 
1stvisit 5.09 0.949 5.26 0.810 0.507 
<0.001 <0.001 P value** 
4th week 1.30 0.765 2.43 0.507 <0.001 
<0.001 <0.001 P value** 
8th  week 0.390 0.499 0.520 0.593 0.458 
<0.001  P value** 
12th  week 0.130 0.344 0.090 0.288 0.639 
<0.001 <0.001 P value** 




Table 13: Lysholm knee score of groups. 
 Control PRP  
Time Mean SD Mean SD P value* 
1st visit 74.61 8.53 76.65 7.40 0.390 
<0.001 <0.001 P value** 
4th week 90.70 5.67 89.30 4.83 0.375 
<0.001 <0.001 P value** 
8th  week 98.65 1.95 98.96 1.67 0.571 
<0.001  P value** 
12th  week 99.70 0.635 99.78 0.518 0.613 
<0.001 <0.001 P value** 
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temporary matrix for cell growth and differentiation. 
Platelets actively secrete pre-synthesized growth 
factors (GF) and synthesize more GFs for several 
days during their life span24. MCL is exrtrasynovial 
and have the potential chance of healing. PRP 
injection in short term (4 weeks) reduces pain more 
therefore rehabilitation program can be accelerated to 
its later stages in a shorter time with sooner returning 
to sport activities, which is a major issue in athletes. 
Completion of functional rehab provides the same 
result but in a longer duration. Our study showed that 
PRP injection causes a significant pain reduction in 
the first month, which allows faster progression of 
rehab, and sooner return to sport activity, though 
control group have that same level of pain reduction 
later, within 12 weeks, and there is no difference in 
Lysholm score or joint stability. Short-term pain 
reduction effect of PRP is definitely beneficial for 
sooner return to play. Short-term pain reduction 
allows faster rehabilitation and sooner return to the 
play, which is beneficial in those who need faster 
recovery including elite athletes so it can be 
recommended to use PRP injection in professional 
athletes with MCL sprains. 
Conclusion 
Based on this study use of injectable PRP in MCL 
sprain cases has a significant short-term pain 
reduction effect while completion of functional 
rehabilitation program is the mainstay of treatment. 
Use of PRP injection can be suggested for 
professional athletes in order to shorten the returning 
time to play and sport. 
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